From: Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
12M dry
12M wet
24M dry
24M wet
36M dry
36M wet
20
2
1
0
3
(69.0%)
(7.0%)
(3.5%)
(6.9%)
(0%)
(10.3%)